What are Sana Biotechnology's total assets?

Sana Biotechnology (SANA) holds $373.6M in total assets, down 16.1% year over year.

How much debt does Sana Biotechnology have?

Sana Biotechnology carries $75.3M in total debt against $119.2M of shareholders' equity, a debt-to-equity ratio of 0.63.

How much cash does Sana Biotechnology have?

Sana Biotechnology holds $83.8M in cash and equivalents.

Can Sana Biotechnology cover its short-term obligations?

Its current ratio is 1.29 — current assets exceed current liabilities.

Where does Sana Biotechnology's balance sheet data come from?

Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Sana Biotechnology SANA Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$83.8M+16.6%	$71.87M-30.5%	$103.36M+45.0%	$71.27M-25.9%	$96.13M-24.6%
Short-term investments	$17.34M-73.9%	$66.51M+33.8%	$49.7M+3,442%	$1.4M-83.6%	$8.57M-65.6%
Restricted cash	$4.2M0.0%	$4.2M0.0%	$4.2M0.0%	$4.2M0.0%	$4.2M+9.5%
Prepaid expenses and other current assets	$6.36M+4.3%	$6.1M+35.2%	$4.51M-19.9%	$5.63M+46.9%	$3.84M-14.4%
Total current assets	$111.69M-24.9%	$148.68M-8.1%	$161.76M+96.1%	$82.5M-26.8%	$112.73M-29.9%
Property and equipment, net	$25.67M-4.6%	$26.91M-10.1%	$29.93M-9.5%	$33.08M-55.1%	$73.69M-4.7%
Operating lease right-of-use assets	$35.85M-6.4%	$38.31M-5.9%	$40.7M-5.4%	$43.02M-21.5%	$54.84M-5.4%
Goodwill	$140.63M0.0%	$140.63M0.0%	$140.63M0.0%	$140.63M0.0%	$140.63M0.0%
Intangible assets, net	$59.2M0.0%	$59.2M0.0%	$59.2M0.0%	$59.2M0.0%	$59.2M0.0%
Other non-current assets	$563K-82.3%	$3.17M-1.3%	$3.22M-0.1%	$3.22M-26.7%	$4.39M-14.2%
Total assets	$373.59M-10.4%	$416.89M-4.3%	$435.43M+20.4%	$361.65M-18.8%	$445.47M-11.1%
Accounts payable	$2.12M+27.2%	$1.67M-10.2%	$1.86M-18.1%	$2.27M+130%	$989K-81.0%
Accrued expenses	$7.58M-42.7%	$13.24M+17.2%	$11.3M+20.0%	$9.41M+0.6%	$9.35M-35.3%
Operating lease liabilities, current	$14.88M-0.4%	$14.94M+4.0%	$14.37M+3.9%	$13.83M+6.4%	$13M+3.7%
Total current liabilities	$86.27M+9.6%	$78.73M+122%	$35.51M+6.2%	$33.44M+0.9%	$33.16M-27.0%
Operating lease liabilities, non-current	$60.45M-5.4%	$63.92M-5.8%	$67.87M-5.3%	$71.66M-8.5%	$78.31M-4.1%
Operating Lease Liabilities (Total)	$75.33M-4.5%	$78.86M-4.1%	$82.24M-3.8%	$85.49M-6.4%	$91.31M-3.1%
Other non-current liabilities	$9.81M-7.5%	$10.6M+34.6%	$7.88M-4.4%	$8.24M-12.7%	$9.44M-4.6%
Total liabilities	$254.35M-0.6%	$256.01M+6.6%	$240.12M+0.4%	$239.09M+1.1%	$236.39M-5.6%
Common stock	$27K0.0%	$27K+3.8%	$26K+13.0%	$23K0.0%	$23K+4.5%
Additional paid-in capital	$2.02B+0.3%	$2.01B+1.2%	$1.99B+6.1%	$1.87B+0.4%	$1.86B+0.4%
Retained earnings	-$1.9B-2.6%	-$1.85B-3.3%	-$1.79B-2.4%	-$1.75B-5.7%	-$1.65B-3.1%
Accumulated other comprehensive income (loss)	-$2K-107%	$28K+33.3%	$21K—	$0—	$0-100%
Total stockholders' equity	$119.24M-25.9%	$160.88M-17.6%	$195.31M+59.4%	$122.56M-41.4%	$209.08M-16.5%
Total liabilities and stockholders' equity	$373.59M-10.4%	$416.89M-4.3%	$435.43M+20.4%	$361.65M-18.8%	$445.47M-11.1%
Short- term Investments	$17.34M-73.9%	$66.51M+33.8%	$49.7M+3,442%	$1.4M-83.6%	$8.57M-65.6%
Deferred Tax Assets and Other Non-Current Assets	$563K-82.3%	$3.17M-1.3%	$3.22M-0.1%	$3.22M-26.7%	$4.39M-14.2%
Net Investment in Lease	$35.85M-6.4%	$38.31M-5.9%	$40.7M-5.4%	$43.02M-21.5%	$54.84M-5.4%
Other intangible assets—net	$59.2M0.0%	$59.2M0.0%	$59.2M0.0%	$59.2M0.0%	$59.2M0.0%
Operating lease right-of-use assets	$35.85M-6.4%	$38.31M-5.9%	$40.7M-5.4%	$43.02M-21.5%	$54.84M-5.4%
Other non-current assets	$563K-82.3%	$3.17M-1.3%	$3.22M-0.1%	$3.22M-26.7%	$4.39M-14.2%
Operating Lease Right-of-Use Assets in Other Assets	$35.85M-6.4%	$38.31M-5.9%	$40.7M-5.4%	$43.02M-21.5%	$54.84M-5.4%
Software and Technology Licenses, Net	$563K-82.3%	$3.17M-1.3%	$3.22M-0.1%	$3.22M-26.7%	$4.39M-14.2%
Accrued Manufacturing Costs	$7.58M-42.7%	$13.24M+17.2%	$11.3M+20.0%	$9.41M+0.6%	$9.35M-35.3%
Compensation and benefits	$7.58M-42.7%	$13.24M+17.2%	$11.3M+20.0%	$9.41M+0.6%	$9.35M-35.3%
Contingent Consideration Liability (Non-Current)	$80.91M-3.1%	$83.52M-27.5%	$115.14M-1.7%	$117.13M+5.7%	$110.83M+1.7%
Accrued expenses and other liabilities	$8.12M-6.4%	$8.68M+8.6%	$7.99M+0.8%	$7.93M-19.2%	$9.81M-25.9%
Total debt	$75.33M-4.5%	$78.86M-4.1%	$82.24M-3.8%	$85.49M-6.4%	$91.31M-3.1%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$27K0.0%	$27K+3.8%	$26K+13.0%	$23K0.0%	$23K+4.5%
Success Payment Liabilities Noncurrent	$16.93M-12.0%	$19.24M+40.2%	$13.73M+59.4%	$8.61M+85.2%	$4.65M+2.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Sana Biotechnology's total assets?: Sana Biotechnology (SANA) holds $373.6M in total assets, down 16.1% year over year.
How much debt does Sana Biotechnology have?: Sana Biotechnology carries $75.3M in total debt against $119.2M of shareholders' equity, a debt-to-equity ratio of 0.63.
How much cash does Sana Biotechnology have?: Sana Biotechnology holds $83.8M in cash and equivalents.
Can Sana Biotechnology cover its short-term obligations?: Its current ratio is 1.29 — current assets exceed current liabilities.
Where does Sana Biotechnology's balance sheet data come from?: Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.